Cargando…
Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms
BACKGROUND: Photoimmunotherapy (PIT) is a novel type of molecular optical imaging-guided cancer phototherapy based on a monoclonal antibody conjugated to a photosensitizer, IR700, in combination with near-infrared (NIR) light. PIT rapidly causes target-specific cell death by inducing cell membrane d...
Autores principales: | Ito, Kimihiro, Mitsunaga, Makoto, Arihiro, Seiji, Saruta, Masayuki, Matsuoka, Mika, Kobayashi, Hisataka, Tajiri, Hisao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727331/ https://www.ncbi.nlm.nih.gov/pubmed/26810644 http://dx.doi.org/10.1186/s12885-016-2072-0 |
Ejemplares similares
-
Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging
por: Ito, Kimihiro, et al.
Publicado: (2016) -
Photoimmunotherapy targeting biliary‐pancreatic cancer with humanized anti‐TROP2 antibody
por: Nishimura, Takashi, et al.
Publicado: (2019) -
Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules
por: Mitsunaga, Makoto, et al.
Publicado: (2011) -
Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy
por: Mitsunaga, Makoto, et al.
Publicado: (2012) -
Correlation between symptomatic improvement and quality of life in patients with reflux and dyspeptic symptoms
por: Arihiro, Seiji, et al.
Publicado: (2012)